Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;75(2):134-45.
doi: 10.1111/aji.12458. Epub 2015 Dec 15.

Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women

Affiliations

Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women

Natasa Strbo et al. Am J Reprod Immunol. 2016 Feb.

Abstract

Problem: Human gamma delta (GD) T cells play a well-documented role in epithelial barrier surveillance and protection. Two subsets of GD T cells, defined by the use of either the Vdelta2 (GD2) or Vdelta1 (GD1) TCR, predominate. We hypothesized that endocervical GD T cells play important role in lower genital tract anti-HIV immune responses.

Method of study: HIV-infected (n = 18) and HIV-uninfected (n = 19) pre-menopausal women participating in the WIHS cohort were recruited. Frequency and phenotype of GD T cells were determined in endocervical cytobrush samples and peripheral blood by multicolor flow cytometry.

Results: We found depletion of GD2 cells in the blood of HIV-infected women as well as significant decrease in the frequency of endocervical GD1 cells compared to uninfected women.

Conclusion: We report for the first time, the GD1 cells are a predominant endocervical T-cell subset that is significantly decreased in HIV-infected women.

Keywords: Biomarker; HIV; female reproductive tract; gamma delta T cells.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Authors do not have commercial or other association that might pose a conflict of interest (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding).

Figures

Figure 1
Figure 1. Representative flow cytometry gating strategy for enumeration of gamma delta (GD) T cell subpopulation in endocervical mucosa
Identification of endocervical T cell populations by following gating strategy: A) Large gate is set on endocervical cytobrush cells B) Exclusion of cell doublets C) Live cells are viability dye-negative population D) CD45 expression on live cells E) CD3 expression on CD45+ cells F) CD4 and CD8 expression on CD3+ cells G) TCRVD1 (GD1) and TCRVD2 (GD2) expression on CD3+ cells H) CD4 and CD8 expression on GD1+ cells I) TCRVD1 expression on gated CD3 negative cells.
Figure 2
Figure 2. Increased GD1 / GD2 T cells ratio in the blood of HIV infected women
PBMC samples from HIV infected and uninfected women were analyzed by flow cytometry A) frequency of GD2+ cells and GD1+ (B) within endocervical CD3+ cells C) combined data from A and B
Figure 3
Figure 3. Endocervical GD1 are predominant GD T cell subset in HIV infected and uninfected women
Endocervical brush samples form HIV infected and uninfected women were analyzed by flow cytometry A) frequency of GD2+ cells and GD1+ (B) within endocervical CD3+ cells C) combined data from A and B D) representative flow cytometry data for HIV negative and HIV positive endocervical CD3+ cells showing expression of TCR VD2 (GD2) and TCR VD1 (GD1).
Figure 4
Figure 4. Phenotypic characteristics of endocervical GD1+ and GD2+ T cells in HIV positive (+) and negative (-) women
Endocervical GD1+ and GD2+ cells were analyzed for expression of surface molecules: CD4, CD8 and CCR5. A) Representative flow cytometry data of gated endocervical CD3+ cells expressing TCR VD2 (GD2+) and TCR VD1 (GD1+) (middle panels). Expression of CD4 and CD8 on GD2+cells (upper panels) and GD1+cells (lower panels). Numbers in the quadrants are showing percent of positive cells. B) Percent of CD4, CD8, double negative (CD4-CD8-) and CCR5+ cells within the GD1 (B and D) and GD2 cells (C and E) in HIV+ and HIV- women.
Figure 4
Figure 4. Phenotypic characteristics of endocervical GD1+ and GD2+ T cells in HIV positive (+) and negative (-) women
Endocervical GD1+ and GD2+ cells were analyzed for expression of surface molecules: CD4, CD8 and CCR5. A) Representative flow cytometry data of gated endocervical CD3+ cells expressing TCR VD2 (GD2+) and TCR VD1 (GD1+) (middle panels). Expression of CD4 and CD8 on GD2+cells (upper panels) and GD1+cells (lower panels). Numbers in the quadrants are showing percent of positive cells. B) Percent of CD4, CD8, double negative (CD4-CD8-) and CCR5+ cells within the GD1 (B and D) and GD2 cells (C and E) in HIV+ and HIV- women.

References

    1. Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. Aids. 2008;22:1909–1917. - PMC - PubMed
    1. Wira CR, Fahey JV, Rodriguez-Garcia M, Shen Z, Patel MV. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. American journal of reproductive immunology. 2014;72:236–258. - PMC - PubMed
    1. Rodriguez-Garcia M, Patel MV, Wira CR. Innate and adaptive anti-HIV immune responses in the female reproductive tract. Journal of reproductive immunology. 2013;97:74–84. - PMC - PubMed
    1. Hayday A, Gibbons D. Brokering the peace: the origin of intestinal T cells. Mucosal immunology. 2008;1:172–174. - PMC - PubMed
    1. Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nature reviews Immunology. 2003;3:233–242. - PubMed

Publication types